Efficacy, Safety, and Tolerability of Inclisiran in Patients With Homozygous Familial Hypercholesterolemia: Results From the ORION-5 Randomized Clinical Trial.
Frederick J RaalRonen DurstRan BiZsolt TalloczyPierre MaheuxAnastasia LesogorJohn J P Kasteleinnull nullPublished in: Circulation (2023)
gov; Unique identifier: NCT03851705.